GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients

$294,654
Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2022 · CA

Arginase Production in Cancer: Evading Immune Response

$294,654
Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2012 · CA

Arginase Production in Cancer: Evading Immune Response

$294,654
Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2015 · CA

Project 2: Mitigating Lung Cancer Disparities in Native Hawaiians: A Population-Based Approach to Evaluate Prevention Barriers and Lung Tumor Biology

$294,649
Sungshim Lani Park · University Of Hawaii At Manoa · P20 · FY2023 · CA

Manipulation of Tumor Specific Immunity

$294,566
Hans Schreiber · University Of Chicago · R01 · FY2009 · CA

FAK and Pky2 in Determination of Glioblastoma Phenotype

$294,554
Mayo Clinic Arizona · R01 · FY2005 · CA

Host's Genes that Control Lymphocyte Infiltration of Tumors

$294,548
Peter Demant · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA

Inflammation in Breast Cancer Initiation and Promotion

$294,526
Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2013 · CA

Project 3- Integrated Stress and Interferon Responses

$294,512
Serge Y Fuchs · University Of Pennsylvania · P01 · FY2023 · CA

Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment

$294,510
Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2019 · CA

CAV-1 Epithelial-Stromal Interactions and Breast Cancer

$294,500
Michael P Lisanti · Thomas Jefferson University · R01 · FY2010 · CA

CAV-1 Epithelial-Stromal Interactions and Breast Cancer

$294,500
Michael P Lisanti · Thomas Jefferson University · R01 · FY2007 · CA

CAV-1 Epithelial-Stromal Interactions and Breast Cancer

$294,500
Michael P Lisanti · Thomas Jefferson University · R01 · FY2008 · CA

CAV-1 Epithelial-Stromal Interactions and Breast Cancer

$294,500
Michael P Lisanti · Thomas Jefferson University · R01 · FY2009 · CA

Advanced Imaging and Dosimetry Core

$294,490
Bryan Patrick Bednarz · University Of Wisconsin-Madison · P01 · FY2021 · CA

Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans

$294,466
Mark M Fuster · Veterans Medical Research Fdn/San Diego · R01 · FY2014 · HL

Role of PI3Kinase in Tumor Progression and Metastasis

$294,438
Judith A. Varner · University Of California, San Diego · R01 · FY2020 · CA

Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion

$294,435
David L Bartlett · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA

Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites

$294,426
David A. Hafler · Yale University · P50 · FY2022 · CA

Core C: Genomics and Bioinformatics

$294,364
Elana Fertig · Johns Hopkins University · P01 · FY2022 · CA

Predicting Tumor Heterogeneity Evolution After Therapy in Patient-derived Ex Vivo Glioblastoma Organoids

$294,336
Aleksander Skardal · Ohio State University · R21 · FY2019 · CA

Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment

$294,335
Kristine Glunde · Johns Hopkins University · R01 · FY2009 · CA

Heparanase regulation of tumor host interactions in myeloma and breast cancer

$294,325
Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2009 · CA

Enhancing HPV-16 E6/E7 Specific Antitumor Immunity

$294,269
T.-C. Wu · Johns Hopkins University · R01 · FY2014 · CA

Regulation of Quiescence in Eukaryotic Cells

$294,261
David Gresham · New York University · R01 · FY2013 · GM